Efficacy and Anti-Inflammatory Activity of Ashwagandha Sustained-Release Formulation on Depression and Anxiety Induced by Chronic Unpredictable Stress: in vivo and in vitro Studies

References

• Micioni Di Bonaventura E, Botticelli L, Del Bello F, et al. Investigating the role of the central melanocortin system in stress and stress-related disorders. Pharmacol Res. 2022;185:106521. doi:10.1016/j.phrs.2022.106521
   PubMed Web of Science ®Google Scholar
• Peng Z, Peng S, Lin K, et al. Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain. J Neuroinflammation. 2022;19(1):186. doi:10.1186/s12974-022-02543-6
   PubMed Web of Science ®Google Scholar
• Woo JM, Postolache TT. The impact of work environment on mood disorders and suicide: evidence and implications. Int J Disabil Hum Dev. 2008;7(2):185–200. doi:10.1515/IJDHD.2008.7.2.185
   PubMedGoogle Scholar
• Tafet GE, Nemeroff CB. The links between stress and depression: psychoneuroendocrinological, genetic, and environmental interactions. J Neuropsychiatry Clin Neurosci. 2016;28(2):77–88. doi:10.1176/appi.neuropsych.15030053
   PubMed Web of Science ®Google Scholar
• Kessler RC, Aguilar-Gaxiola S, Alonso J, et al. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc. 2009;18(1):23–33. doi:10.1017/S1121189X00001421
   PubMed Web of Science ®Google Scholar
• Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17(3):327–335. doi:10.31887/DCNS.2015.17.3/bbandelow
   PubMed Web of Science ®Google Scholar
• World Health Organization. 2016 Fact Sheet on Depression. Genevas: World Health Organization; 2016.
   Google Scholar
• Kyrou I, Christou A, Panagiotakos D, et al. Effects of a hops (Humulus lupulus L.) dry extract supplement on self-reported depression, anxiety and stress levels in apparently healthy young adults: a randomized, placebo-controlled, double-blind, crossover pilot study. Hormones. 2017;16(2):171–180. doi:10.14310/horm.2002.1738
   PubMedGoogle Scholar
• Calcia MA, Bonsall DR, Bloomfield PS, Selvaraj S, Barichello T, Howes OD. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology. 2016;233(9):1637–1650. doi:10.1007/s00213-016-4218-9
   PubMed Web of Science ®Google Scholar
• Grippo AJ, Scotti MA. Stress and neuroinflammation. Mod Trends Pharmacopsychiatry. 2013;28:20–32.
   PubMedGoogle Scholar
• Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract. 2012;66(10):924–939. doi:10.1111/j.1742-1241.2012.02945.x
   PubMed Web of Science ®Google Scholar
• Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008;12:1–23.
   PubMedGoogle Scholar
• Verma S. Therapeutic uses of Withania somnifera (Ashwagandha) with a note on withanolides and its pharmacological actions. Asian J Pharm Clin Res. 2011;4:1.
   Google Scholar
• Singh N, Bhalla M, de Jager P, Gilca M. An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med. 2011;8(5 Suppl):208–213. doi:10.4314/ajtcam.v8i5S.9
   PubMedGoogle Scholar
• Jahanbakhsh SP, Manteghi AA, Emami SA, et al. Evaluation of the efficacy of Withania somnifera (Ashwagandha) root extract in patients with obsessive-compulsive disorder: a randomized double-blind placebo-controlled trial. Complement Ther Med. 2016;27:25–29. doi:10.1016/j.ctim.2016.03.018
   PubMed Web of Science ®Google Scholar
• Chengappa KN, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal R. Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder. J Clin Psychiatry. 2013;74(11):1076–1083. doi:10.4088/JCP.13m08413
   PubMed Web of Science ®Google Scholar
• Chengappa KNR, Brar JS, Gannon JM, Schlicht PJ. Adjunctive use of a standardized extract of withania somnifera (Ashwagandha) to treat symptom exacerbation in schizophrenia: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2018;79(5). doi:10.4088/JCP.17m11826
   PubMed Web of Science ®Google Scholar
• Mirjalili MH, Fakhr-Tabatabaei SM, Alizadeh H, Ghassempour A, Mirzajani F. Genetic and withaferin A analysis of Iranian natural populations of Withania somnifera and W. coagulans by RAPD and HPTLC. Nat Prod Commun. 2009;4(3):337–346.
   PubMed Web of Science ®Google Scholar
• Gupta M, Kaur G. Aqueous extract from the Withania somnifera leaves as a potential anti-neuroinflammatory agent: a mechanistic study. J Neuroinflammation. 2016;13(1):193. doi:10.1186/s12974-016-0650-3
   PubMedGoogle Scholar
• Gupta M, Kaur G. Withania somnifera as a potential anxiolytic and anti-inflammatory candidate against systemic lipopolysaccharide-induced neuroinflammation. Neuromolecular Med. 2018;20(3):343–362. doi:10.1007/s12017-018-8497-7
   PubMed Web of Science ®Google Scholar
• Kaur T, Singh H, Mishra R, et al. Withania somnifera as a potential anxiolytic and immunomodulatory agent in acute sleep deprived female Wistar rats. Mol Cell Biochem. 2017;427(1–2):91–101. doi:10.1007/s11010-016-2900-1
   PubMed Web of Science ®Google Scholar
• Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine. 2000;7(6):463–469. doi:10.1016/S0944-7113(00)80030-6
   PubMed Web of Science ®Google Scholar
• Pratte MA, Nanavati KB, Young V, Morley CP. An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). J Altern Complement Med. 2014;20(12):901–908. doi:10.1089/acm.2014.0177
   PubMed Web of Science ®Google Scholar
• Remenapp A, Coyle K, Orange T, et al. Efficacy of Withania somnifera supplementation on adult’s cognition and mood. J Ayurveda Integr Med. 2022;13(2):100510. doi:10.1016/j.jaim.2021.08.003
   PubMed Web of Science ®Google Scholar
• Auddy B, Hazra J, Mitra A, Abedon B, Ghosal S. A standardized withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans: a double-blind, randomized, placebo-controlled study. J Am Nutraceut Ass. 2008;11:50–56.
   Google Scholar
• Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255–262. doi:10.4103/0253-7176.106022
   PubMedGoogle Scholar
• Laufs U, Rettig-Ewen V, Böhm M. Strategies to improve drug adherence. Eur Heart J. 2011;32(3):264–268. doi:10.1093/eurheartj/ehq297
   PubMed Web of Science ®Google Scholar
• Li H, Zhang M, Xiong L, Feng W, Williams RO. Bioavailability improvement of carbamazepine via oral administration of modified-release amorphous solid dispersions in rats. Pharmaceutics. 2020;12(11):1023. doi:10.3390/pharmaceutics12111023
   PubMed Web of Science ®Google Scholar
• Perals Bertomeu D, Griffin A, Bartomeus I, Sol D. Revisiting the open-field test: what does it really tell us about animal personality? Anim Behav. 2017;2017:123.
   Google Scholar
• Seibenhener ML, Wooten MC, Use of the open field maze to measure locomotor and anxiety-like behavior in mice. J Vis Exp. 2015;96:e52434. doi:10.3791/52434
   PubMed Web of Science ®Google Scholar
• da Silva Marques JG, Antunes FTT, da Silva Brum LF, et al. Adaptogenic effects of curcumin on depression induced by moderate and unpredictable chronic stress in mice. Behav Brain Res. 2021;399:113002. doi:10.1016/j.bbr.2020.113002
   PubMed Web of Science ®Google Scholar
• Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc. 2007;2(2):322–328. doi:10.1038/nprot.2007.44
   PubMed Web of Science ®Google Scholar
• Can A, Dao DT, Arad M, Terrillion CE, Piantadosi SC, Gould TD, The mouse forced swim test. J Vis Exp. 2012;59:e3638. doi:10.3791/3638
   PubMed Web of Science ®Google Scholar
• Yankelevitch-Yahav R, Franko M, Huly A, Doron R. The forced swim test as a model of depressive-like behavior. J Vis Exp. 2015;(97). doi:10.3791/52587
   Web of Science ®Google Scholar
• Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1(2):848–858. doi:10.1038/nprot.2006.116
   PubMed Web of Science ®Google Scholar
• Venkataramaiah C, Gunduluru S, Rajendra W. Morris water maze – a benchmark test for learning and memory disorders in animal models: a review. Asian J Pharm Clin Res. 2018;11:25. doi:10.22159/ajpcr.2018.v11i5.24292
   Google Scholar
• Zhang L, Fang Y, Xu Y, et al. Curcumin Improves Amyloid β-Peptide (1-42) induced spatial memory deficits through BDNF-ERK signaling pathway. PLoS One. 2015;10(6):e0131525. doi:10.1371/journal.pone.0131525
   PubMed Web of Science ®Google Scholar
• Monteiro S, Roque S, de Sá-calçada D, Sousa N, Correia-Neves M, Cerqueira JJ. An efficient chronic unpredictable stress protocol to induce stress-related responses in C57BL/6 mice. Front Psychiatry. 2015;6:6. doi:10.3389/fpsyt.2015.00006
   PubMed Web of Science ®Google Scholar
• Bondi CO, Rodriguez G, Gould GG, Frazer A, Morilak DA. Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology. 2008;33(2):320–331. doi:10.1038/sj.npp.1301410
   PubMed Web of Science ®Google Scholar
• Patil D, Gautam M, Mishra S, et al. Determination of withaferin A and withanolide A in mice plasma using high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral administration of Withania somnifera aqueous extract. J Pharm Biomed Anal. 2013;80:203–212. doi:10.1016/j.jpba.2013.03.001
   PubMed Web of Science ®Google Scholar
• Dahikar PRK, Sahni Y. Pharmacokinetics of Withania somnifera (Ashwagandha) in healthy Buffalo calves. Buffalo Bull. 2012;31(4):219–223.
   Web of Science ®Google Scholar
• Dey A, Chatterjee SS, Kumar V. Triethylene glycol-like effects of Ashwagandha (Withania somnifera (L.) Dunal) root extract devoid of withanolides in stressed mice. Ayu. 2018;39(4):230–238. doi:10.4103/ayu.AYU_219_16
   PubMedGoogle Scholar
• Alzoubi KH, Al Hilo AS, Al-Balas QA, El-Salem K, El-Elimat T, Alali FQ. Withania somnifera root powder protects against post-traumatic stress disorder-induced memory impairment. Mol Biol Rep. 2019;46(5):4709–4715. doi:10.1007/s11033-019-04915-3
   PubMed Web of Science ®Google Scholar
• Jain S, Shukla SD, Sharma K, Bhatnagar M. Neuroprotective effects of Withania somnifera Dunn. in hippocampal sub-regions of female albino rat. Phytother Res. 2001;15(6):544–548. doi:10.1002/ptr.802
   PubMed Web of Science ®Google Scholar
• Mineur YS, Prasol DJ, Belzung C, Crusio WE. Agonistic behavior and unpredictable chronic mild stress in mice. Behav Genet. 2003;33(5):513–519. doi:10.1023/A:1025770616068
   PubMed Web of Science ®Google Scholar
• Dubey VK, Ansari F, Vohora D, Khanam R. Possible involvement of corticosterone and serotonin in antidepressant and antianxiety effects of chromium picolinate in chronic unpredictable mild stress induced depression and anxiety in rats. J Trace Elem Med Biol. 2015;29:222–226. doi:10.1016/j.jtemb.2014.06.014
   PubMed Web of Science ®Google Scholar
• Karson A, Demirtaş T, Bayramgürler D, Balci F, Utkan T. Chronic administration of infliximab (TNF-α inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress. Basic Clin Pharmacol Toxicol. 2013;112(5):335–340. doi:10.1111/bcpt.12037
   PubMed Web of Science ®Google Scholar
• Zhang W, Yan Y, Wu Y, et al. Medicinal herbs for the treatment of anxiety: a systematic review and network meta-analysis. Pharmacol Res. 2022;179:106204. doi:10.1016/j.phrs.2022.106204
   PubMed Web of Science ®Google Scholar
• Herrera AJ, Espinosa-Oliva AM, Oliva-Martin MJ, Carrillo-Jimenez A, Venero JL, de Pablos RM. Collateral damage: contribution of peripheral inflammation to neurodegenerative diseases. Curr Top Med Chem. 2015;15(21):2193–2210. doi:10.2174/1568026615666150610142027
   PubMed Web of Science ®Google Scholar
• Zubair Alam M, Alam Q, Amjad Kamal M, et al. Infectious agents and neurodegenerative diseases: exploring the links. Curr Top Med Chem. 2017;17(12):1390–1399. doi:10.2174/1568026617666170103164040
   PubMed Web of Science ®Google Scholar
• Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8(1):57–69. doi:10.1038/nrn2038
   PubMed Web of Science ®Google Scholar
• Lynch MA. The multifaceted profile of activated microglia. Mol Neurobiol. 2009;40(2):139–156. doi:10.1007/s12035-009-8077-9
   PubMed Web of Science ®Google Scholar
• Lull ME, Block ML. Microglial activation and chronic neurodegeneration. Neurotherapeutics. 2010;7(4):354–365. doi:10.1016/j.nurt.2010.05.014
   PubMed Web of Science ®Google Scholar
• Suganya K, Kayalvizhi E, Yuvaraj R, Chandrasekar M, Kavitha U, Konakanchi Suresh K. Effect of Withania Somnifera on the antioxidant and neurotransmitter status in sleep deprivation induced Wistar rats. Bioinformation. 2020;16(8):631–637. doi:10.6026/97320630016631
   PubMed Web of Science ®Google Scholar
• Balkrishna A, Solleti SK, Singh H, Sharma N, Varshney A. Withanolides from withania somnifera ameliorate neutrophil infiltration in endotoxin-induced peritonitis by regulating oxidative stress and inflammatory cytokines. Planta Med. 2022;88(6):466–478. doi:10.1055/a-1438-2816
   PubMedGoogle Scholar
• Rasool M, Varalakshmi P. Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: an in vivo and in vitro study. Vascul Pharmacol. 2006;44(6):406–410. doi:10.1016/j.vph.2006.01.015
   PubMed Web of Science ®Google Scholar
• Grunz-Borgmann E, Mossine V, Fritsche K, Parrish AR. Ashwagandha attenuates TNF-α- and LPS-induced NF-κB activation and CCL2 and CCL5 gene expression in NRK-52E cells. BMC Complement Altern Med. 2015;15:434. doi:10.1186/s12906-015-0958-z
   PubMed Web of Science ®Google Scholar
• Trivedi MK, Mondal SC, Gangwar M, Jana S. Effect of a novel ashwagandha-based herbomineral formulation on pro-inflammatory cytokines expression in mouse splenocyte cells: a potential immunomodulator. Pharmacogn Mag. 2017;13(Suppl 1):S90–s94. doi:10.4103/0973-1296.197709
   PubMedGoogle Scholar
• Gupta GL, Rana AC. Protective effect of Withania somnifera dunal root extract against protracted social isolation induced behavior in rats. Indian J Physiol Pharmacol. 2007;51(4):345–353.
   PubMedGoogle Scholar